Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank77
3Y CAGR+4.4%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+4.4%/yr
vs -14.7%/yr prior
Acceleration
+19.1pp
Accelerating
Percentile
P77
Within normal range
vs 3Y Ago
1.1x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 10.98% |
| Q3 2025 | -9.33% |
| Q2 2025 | 7.41% |
| Q1 2025 | -12.50% |
| Q4 2024 | -1.41% |
| Q3 2024 | -33.96% |
| Q2 2024 | 77.45% |
| Q1 2024 | -235.71% |
| Q4 2023 | 7.89% |
| Q3 2023 | 7.32% |
| Q2 2023 | 9.89% |
| Q1 2023 | -21.33% |
| Q4 2022 | 9.64% |
| Q3 2022 | 6.74% |
| Q2 2022 | 15.24% |
| Q1 2022 | -23.53% |
| Q4 2021 | -21.43% |
| Q3 2021 | 0.00% |
| Q2 2021 | -176.09% |
| Q1 2021 | 216.46% |
| Q4 2020 | -2.60% |
| Q3 2020 | -8.45% |
| Q2 2020 | 8.97% |
| Q1 2020 | 0.00% |
| Q4 2019 | 25.00% |
| Q3 2019 | 16.13% |
| Q2 2019 | -47.62% |
| Q1 2019 | -13.51% |
| Q4 2018 | -42.31% |
| Q3 2018 | 0.00% |
| Q2 2018 | 13.33% |
| Q1 2018 | -50.00% |
| Q4 2017 | -5.26% |
| Q3 2017 | -46.15% |
| Q2 2017 | 31.58% |
| Q1 2017 | 24.00% |
| Q4 2016 | -31.58% |
| Q3 2016 | 40.63% |
| Q2 2016 | -4.92% |
| Q1 2016 | 7.58% |